Federated Hermes Portfolio holdings
AUM
$53.1B
1-Year Return
30.23%
This Quarter Return
+14.33%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$40.3B
AUM Growth
+$2.76B
(+7.3%)
Cap. Flow
-$1.61B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
13.58%
Holding
2,266
New
182
Increased
650
Reduced
1,111
Closed
232
Top Buys
| 1 |
GoDaddy
GDDY
|
$98.5M |
| 2 |
Morgan Stanley
MS
|
$78.9M |
| 3 |
AbbVie
ABBV
|
$67.8M |
| 4 |
Kenvue
KVUE
|
$65.1M |
| 5 |
GE Aerospace
GE
|
$61.2M |
Top Sells
| 1 |
Amgen
AMGN
|
$219M |
| 2 |
Williams Companies
WMB
|
$149M |
| 3 |
Verizon
VZ
|
$136M |
| 4 |
SPLK
Splunk Inc
SPLK
|
$123M |
| 5 |
PNC Financial Services
PNC
|
$97.4M |
Sector Composition
| 1 | Healthcare | 18.2% |
| 2 | Technology | 16.32% |
| 3 | Financials | 12.58% |
| 4 | Industrials | 9.74% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Daktronics
DAKT
$854M
| $1.31K | ﹤0.01% |
155
+55
| +55% | +$466 |
|
1952
Build-A-Bear
BBW
$854M
| $1.29K | ﹤0.01% |
+56
| New | +$1.29K |
|
1953
Trevi Therapeutics
TRVI
$854M
| $1.27K | ﹤0.01% |
+950
| New | +$1.27K |
|
|
ZUO
1954
DELISTED
Zuora, Inc.
ZUO
| $1.23K | ﹤0.01% |
131
-29,631
| -100% | -$278K |
|
1955
Caesarstone
CSTE
$48.7M
| $1.21K | ﹤0.01% |
324
-86
| -21% | -$322 |
|
1956
Workhorse Group
WKHS
$19.4M
| $1.2K | ﹤0.01% |
13
+7
| +117% | +$645 |
|
1957
Neuropace
NPCE
$322M
| $1.2K | ﹤0.01% |
116
-308
| -73% | -$3.18K |
|
1958
Synchronoss Technologies
SNCR
$61.8M
| $1.18K | ﹤0.01% |
190
-340
| -64% | -$2.11K |
|
1959
Ichor Holdings
ICHR
$579M
| $1.18K | ﹤0.01% |
+35
| New | +$1.18K |
|
1960
Evolution Petroleum
EPM
$174M
| $1.17K | ﹤0.01% |
+201
| New | +$1.17K |
|
1961
First Bancorp
FBP
$3.54B
| $1.17K | ﹤0.01% |
71
-2,762
| -97% | -$45.4K |
|
|
MACK
1962
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.14K | ﹤0.01% |
85
-3
| -3% | -$40 |
|
1963
Hovnanian Enterprises
HOV
$908M
| $1.09K | ﹤0.01% |
7
-43
| -86% | -$6.69K |
|
|
OKUR
1964
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
| $1.04K | ﹤0.01% |
65
-5,945
| -99% | -$94.7K |
|
1965
Jakks Pacific
JAKK
$196M
| $995 | ﹤0.01% |
+28
| New | +$995 |
|
1966
ImmunityBio
IBRX
$2.27B
| $989 | ﹤0.01% |
197
-63
| -24% | -$316 |
|
1967
Hyliion Holdings
HYLN
$309M
| $979 | ﹤0.01% |
+1,203
| New | +$979 |
|
1968
Sutro Biopharma
STRO
$89.9M
| $957 | ﹤0.01% |
223
-6,164
| -97% | -$26.5K |
|
1969
Immunome
IMNM
$916M
| $931 | ﹤0.01% |
+87
| New | +$931 |
|
1970
Immunic
IMUX
$75.1M
| $921 | ﹤0.01% |
+614
| New | +$921 |
|
|
WHWK
1971
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.8M
| $919 | ﹤0.01% |
+455
| New | +$919 |
|
1972
Xperi
XPER
$284M
| $893 | ﹤0.01% |
+81
| New | +$893 |
|
1973
Wave Life Sciences
WVE
$1.32B
| $874 | ﹤0.01% |
173
-141
| -45% | -$712 |
|
1974
Veritone
VERI
$147M
| $871 | ﹤0.01% |
+481
| New | +$871 |
|
1975
Cadre Holdings
CDRE
$1.3B
| $855 | ﹤0.01% |
+26
| New | +$855 |
|